Charlotte joined AHMB in 2024, where she oversees day-to-day operations, quality systems, and governance processes, ensuring the biobank meets all ethical, legal and regulatory requirements related to biobanking and donor confidentiality. She also manages key projects that support the strategic development and continuous improvement of the facility, including AHMB’s accreditation process with the National Association of Testing Authorities (NATA).
Prior to that, Charlotte worked at Microba Life Sciences where she isolated fastidious gut bacteria and helped assess their therapeutic efficacy in support of Microba’s Therapeutics programs. Several of these species were previously uncultured and her efforts have provided new insights into the functional capacities of these species.